Correction to: New CEACAM-targeting 2A3 single-domain antibody-based chimeric antigen receptor T-cells produce anticancer effects in vitro and in vivo.

Autor: Jancewicz, Iga, Śmiech, Magdalena, Winiarska, Magdalena, Zagozdzon, Radoslaw, Wisniewski, Pawel
Zdroj: Cancer Immunology, Immunotherapy; Sep2024, Vol. 73 Issue 9, p1-1, 1p
Databáze: Complementary Index
Externí odkaz: